Comparison of the efficacy of ephedrine versus norepinephrine in the treatment of hypotension occurring after induction of general anesthesia in patients with chronic renal failure.
- Conditions
- Hypotension occurring post-induction of general anesthesia in patients with chronic renal failure during elective surgery.MedDRA version: 21.1Level: LLTClassification code 10009119Term: Chronic renal failureSystem Organ Class: 100000004857MedDRA version: 20.0Level: PTClassification code 10021097Term: HypotensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2022-002892-12-BE
- Lead Sponsor
- CHU Brugmann
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Age between 18 and 75 years old
Signed informed consent
Elective, non-cardiac surgery
General anaesthesia
Chronic renal failure with a GFR less than 45ml/min/m2 (stages below grade 3b and chronically on dialysis).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 35
Congestive heart failure with LVEF < 50%
Moderate or severe cardiomyopathy or valvulopathy
History of atrial or ventricular arrhythmia
Taking drugs from the class of ACE inhibitors and sartans <24 hours before anesthesia
Chronic treatment with central antihypertensives such as a2 agonists
Chronic treatment with antidepressants of the following classes: selective norepinephrine reuptake inhibitors, tricyclic antidepressants, serotonin and norepinephrine reuptake inhibitors, norepinephrine and dopamine reuptake inhibitors, monoamine oxidase inhibitors.
BMI <18.5kg/m2 or >35kg/m2
ASA score = 4
Pregnant women
Allergy to a product used for anesthesia
Prone position required during surgery.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method